A high-resolution 3D epigenomic map reveals insights into the creation of the prostate cancer transcriptome.
Suhn Kyong RhieAndrew A PerezFides D LayShannon M SchreinerJiani ShiJenevieve PolinPeggy J FarnhamPublished in: Nature communications (2019)
To better understand the impact of chromatin structure on regulation of the prostate cancer transcriptome, we develop high-resolution chromatin interaction maps in normal and prostate cancer cells using in situ Hi-C. By combining the in situ Hi-C data with active and repressive histone marks, CTCF binding sites, nucleosome-depleted regions, and transcriptome profiling, we identify topologically associating domains (TADs) that change in size and epigenetic states between normal and prostate cancer cells. Moreover, we identify normal and prostate cancer-specific enhancer-promoter loops and involved transcription factors. For example, we show that FOXA1 is enriched in prostate cancer-specific enhancer-promoter loop anchors. We also find that the chromatin structure surrounding the androgen receptor (AR) locus is altered in the prostate cancer cells with many cancer-specific enhancer-promoter loops. This creation of 3D epigenomic maps enables a better understanding of prostate cancer biology and mechanisms of gene regulation.
Keyphrases
- prostate cancer
- transcription factor
- gene expression
- radical prostatectomy
- dna methylation
- genome wide
- high resolution
- single cell
- dna binding
- rna seq
- dna damage
- genome wide identification
- binding protein
- squamous cell carcinoma
- oxidative stress
- papillary thyroid
- electronic health record
- lymph node metastasis
- high speed